Cardiovascular Monitoring With Trastuzumab Therapy: How Frequent Is Too Frequent?
Rush Medical College, Chicago, Illinois.
Alison M
AM
Brann
Section of Medical Oncology, Rush University Medical Center, Chicago, Illinois.
Melody A
MA
Cobleigh
Division of Cardiology, Rush University Medical Center, Chicago, Illinois.
Tochi M
TM
Okwuosa
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D066126:Cardiotoxicity / Q000000981:diagnostic imaging / Q000209:etiology; D017024:Chemotherapy, Adjuvant; D016903:Drug Monitoring; D004452:Echocardiography; D005260:Female; D006801:Humans; D013318:Stroke Volume; D000068878:Trastuzumab / Q000009:adverse effects*; D018487:Ventricular Dysfunction, Left / Q000139:chemically induced / Q000000981:diagnostic imaging*
D000970:Antineoplastic Agents; D000068878:Trastuzumab